NDATOPICALLOTION
Approved
Apr 2019
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
2
Mechanism of Action
signaling, immune function, inflammation, and protein regulation; however, the precise mechanism of action in plaque psoriasis is unknown. Tazarotene is a retinoid prodrug which is converted to its active form, tazarotenic acid, the carboxylic acid of tazarotene, by deesterification. Tazarotenic…
Pharmacologic Class:
Retinoid
Indications (1)
Clinical Trials (2)
Duobrii Treatment of Acne Keloidalis Nuchae (AKN)
Started Oct 2022
15 enrolled
Acne Keloidalis NuchaeAKN
Combination of Halobetasol Propionate and Tazarotene Lotion (Duobrii®) for Palmoplantar Plaque Type Psoriasis
Started Nov 2020
22 enrolled
Palmoplantar PsoriasisPlaque Psoriasis
Loss of Exclusivity
LOE Date
Jun 6, 2036
124 months away
Patent Expiry
Jun 6, 2036